Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Sch-417690

Known as: SCH-D, Sch 417690, Sch417690 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Vicriviroc or SCH 417690 is a potent and selective antagonist of the CCR5 receptor. CCR5 receptor antagonists have the potential… 
2011
2011
The threshold condition in long-wavelength InAlGaAs/InP transistor lasers is theoretically and numerically investigated. The… 
  • figure 1
  • figure 2
  • figure 5
  • figure 3
  • figure 4
2008
2008
In addition to being an important receptor in leukocyte activation and mobilization, CCR5 is the essential coreceptor for human… 
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2007
Highly Cited
2007
Human immunodeficiency virus type 1 (HIV-1) infection can be inhibited by small molecules that target the CCR5 coreceptor. Here… 
Review
2006
Review
2006
Entry inhibitors constitute a new drug class for treatment of HIV-1 infection. They are divided into subclasses, each aiming at a… 
Highly Cited
2005
Highly Cited
2005
We describe the generation of two genetically related human immunodeficiency virus type 1 (HIV-1) isolates highly (>20,000-fold… 
2005
2005
Method of treating HIV infection due to the fact that both the administration of tipranavir and SCH-417690. 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Inhibiting human immunodeficiency virus type 1 (HIV-1) infection by blocking the host cell coreceptors CCR5 and CXCR4 is… 
Highly Cited
1989
Highly Cited
1989
D adc County, Florida, has made front-page headlines with its pilot School-Based Manage ment/Shared Decision Making Pro gram The…